Zejula tablets 100mg, with the ingredient Niraparibut tosilate hydrate, are produced by Takeda Pharmaceutical. This medication (YJ code: 4291068F1028, 100mg 1 tablet) is a PARP inhibitor indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Zejula tablets 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →